Coronary Microvascular Dysfunction: Epidemiology, Clinical Presentation, Diagnosis and Treatment

被引:0
|
作者
Trisvetova, E. L. Coronary [1 ]
机构
[1] Belarusian State Med Univ, Minsk, BELARUS
关键词
microvascular dysfunction; coronary arteries; microvascular angina; diagnostics; treatment; CARDIOLOGY-WORKING GROUP; ARTERY-DISEASE; CHEST-PAIN; MYOCARDIAL-ISCHEMIA; EUROPEAN-SOCIETY; POSITION PAPER; FLOW RESERVE; RISK-FACTORS; WOMEN; HEART;
D O I
10.20996/1819-6446-2023-04-02
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a significant number of patients with symptoms of angina pectoris or myocardial infarction with ischemic changes in the myocardium, according to the results of instrumental research methods, there is no hemodynamically significant stenosis of the coronary arteries. In these cases, vasospastic angina or microvascular dysfunction is considered the cause of coronary heart disease. Coronary microvascular dysfunction is caused by several patho-logical mechanisms that cause structural and functional disorders in the microvascular bed of the heart. Clinical groups of coronary microvascular dys-function include angina pectoris and myocardial ischemia without obstructive coronary artery disease (primary coronary microvascular dysfunction), in combination with coronary atherosclerosis, with myocardial damage and iatrogenic nature. Diagnostics of microvascular disorders is carried out on the basis of the results of non-invasive and invasive methods, which make it possible to clarify the nature of the changes and choose an effective non drug and drug treatment. The prognosis for coronary microvascular dysfunction is poor, due to the development of cardiovascular complications and death, a high risk of disability, and a decrease in the quality of life of patients.
引用
收藏
页码:186 / 196
页数:11
相关论文
共 50 条
  • [21] Response to Letter Regarding Article, "Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management"
    Lanza, Gaetano A.
    Crea, Filippo
    CIRCULATION, 2011, 123 (04) : E213 - E213
  • [22] Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management
    Bechsgaard, Daria Frestad
    Prescott, Eva
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (09)
  • [23] Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management
    Daria Frestad Bechsgaard
    Eva Prescott
    Current Atherosclerosis Reports, 2021, 23
  • [24] Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction
    Sharp, Randall P.
    Patatanian, Edna
    Sirajuddin, Riaz
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 513 - 521
  • [25] Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction
    Randall P. Sharp
    Edna Patatanian
    Riaz Sirajuddin
    American Journal of Cardiovascular Drugs, 2021, 21 : 513 - 521
  • [26] Epidemiology, clinical presentation, and diagnosis of cervical dystonia
    Stacy, Mark
    NEUROLOGIC CLINICS, 2008, 26 : 23 - 42
  • [27] Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
    Elbaum, Lindsay
    Tomacruz, Isabelle Dominique V.
    Bangalore, Sripal
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (01): : 10 - 13
  • [28] DISTINCT CLINICAL AND PHYSIOLOGICAL SUBTYPES OF CORONARY MICROVASCULAR DYSFUNCTION
    Rahman, Haseeb
    Khan, Faisal
    Ryan, Matthew
    Ellis, Howard
    Clapp, Brian
    Webb, Andrew
    Perera, Divaka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1420 - 1420
  • [29] New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction
    Ahmed, Bina
    CORONARY ARTERY DISEASE, 2014, 25 (05) : 439 - 449
  • [30] Coronary microvascular dysfunction
    Zhu, Chunlin
    Miao, Lina
    Wei, Kangkang
    Shi, Dazhuo
    Gao, Jie
    MICROVASCULAR RESEARCH, 2024, 153